Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/d5b9or2vpe95/public_html/ixplifesciences.com/wp-includes/functions.php on line 6260

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the tpebl domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/d5b9or2vpe95/public_html/ixplifesciences.com/wp-includes/functions.php on line 6260

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the theplus domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/d5b9or2vpe95/public_html/ixplifesciences.com/wp-includes/functions.php on line 6260
The Fund – ixplifesciences
Investing

Beyond Capital

Our philosophy is to act as strategic partners for portfolio companies to build viable and sustained businesses. The Lifesciences domain, especially, is nuanced with each start-up navigating its own meandering path. As an investor, we help companies traverse their individual journeys rather than use a cookie-cutter approach.
Four Cornerstones of the Fund

  • Value Creation: While financial returns are paramount, we are strong proponents of value creation for our portfolio by driving innovation, expanding market share, enhancing competitive advantage, and unlocking new growth avenues.
  • Synergies and Collaboration: Science does not thrive in silos, so it is crucial to build collaborative partnerships and explore synergies between investors and investee companies.
  • Long-Term Vision: Alignment on the best exit strategies for start-ups is important in the initial stages. Not only does it bring a long-term perspective but also creates a collective commitment to sustainable growth.
  • Industry Expertise: Given the length and breadth of Lifesciences industry, tapping into the experience and expertise of seasoned scientists, veterans and mentors is key to creating successful enterprises.
Our USP: The PoweRx Ecosystem

Just like it takes a village to raise a child, it takes an ecosystem to nurture a start-up. And we bring just that to our portfolio companies through PoweRx, an ensemble of niche Lifesciences and Healthcare businesses within our parent group, JV Ventures.

Through Rx Propellant, a leading Lifesciences infrastructure platform, we provide our portfolio companies access to compliant R&D labs in key clusters across India. On the other hand, start-ups can maintain lean operations by leveraging GVRP, a bespoke in-house CRO, for chemistry/biology services and dedicated CoE setup. Furthermore, they can benefit from GV Connect, a non-profit networking platform for the scientific community for forging partnerships and collaborations.

The vibrant PoweRx ecosystem with diverse businesses, clientele and partners also channels new investment and co-creation opportunities into the Fund.